Evaluating the effect of oral Propranolol in preventing the progression of retinopathy of prematurity

Evaluating the effect of oral Propranolol in pereventing the progression of retinopathy of prematurity

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230717058817N1

Enrollment

Registered

2023-07-24

Start date

2023-03-21

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinopathy of prematurity. Retinopathy of prematurity, unspecified, bilateral

Interventions

Intervention 1: The intervention group will receive oral Propranolol at a dosage of 0.5 mg per kilogram every 8 hours (24 doses) until the completion of retinal vessels or discharge. It is important t

Eligibility

Sex/Gender

All

Age

1 Months to 6 Months

Inclusion criteria

Inclusion criteria: Infants , with a gestational age of less than 32 weeks or a birth weight below 1500 grams,

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Retinal vascularization. Timepoint: Weekly. Method of measurement: Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Najafi

Ardabil University of Medical Sciences

amin.najafi.dr@gmail.com+98 45 3325 2827

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026